MUSLF (Promino Nutritional Sciences) Cash Flow from Financing: $1.08 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Promino Nutritional Sciences Cash Flow from Financing?

Promino Nutritional Sciences MUSLF -5.66% Cash Flow from Financing is $1.08 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2026, Promino Nutritional Sciences received $0.80 Mil more from issuing new shares than it paid to buy back shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It spent $0.08 Mil on other financial activities. In all, Promino Nutritional Sciences earned $0.72 Mil on financial activities for the three months ended in Mar. 2026.


Promino Nutritional Sciences  (OTCPK:MUSLF) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Promino Nutritional Sciences's issuance of stock for the three months ended in Mar. 2026 was $0.80 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Promino Nutritional Sciences's repurchase of stock for the three months ended in Mar. 2026 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Promino Nutritional Sciences's net issuance of debt for the three months ended in Mar. 2026 was $0.00 Mil. Promino Nutritional Sciences received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Promino Nutritional Sciences's net issuance of preferred for the three months ended in Mar. 2026 was $0.00 Mil. Promino Nutritional Sciences paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Promino Nutritional Sciences's cash flow for dividends for the three months ended in Mar. 2026 was $0.00 Mil. Promino Nutritional Sciences received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Promino Nutritional Sciences's other financing for the three months ended in Mar. 2026 was $-0.08 Mil. Promino Nutritional Sciences spent $0.08 Mil on other financial activities.


Promino Nutritional Sciences Cash Flow from Financing Related Terms


Promino Nutritional Sciences Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Promino Nutritional Sciences's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promino Nutritional Sciences Cash Flow from Financing Chart

Promino Nutritional Sciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Financing
Get a 7-Day Free Trial 8.24 3.16 1.28 2.40 0.00

Promino Nutritional Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.37 0.00 0.00 0.72

Promino Nutritional Sciences Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Promino Nutritional Sciences's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:

Promino Nutritional Sciences's Cash from Financing for the quarter that ended in Mar. 2026 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of $1.08 Mil mean?
Promino Nutritional Sciences (MUSLF) has a Cash Flow from Financing of $1.08 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Promino Nutritional Sciences and its competitors.
Is Promino Nutritional Sciences' Cash Flow from Financing too high?
Promino Nutritional Sciences' current Cash Flow from Financing is $1.08 Mil.
How does Promino Nutritional Sciences' Cash Flow from Financing compare to KHC and GIS?
Promino Nutritional Sciences' Cash Flow from Financing of $1.08 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Consumer Packaged Goods company?
A good Cash Flow from Financing depends on the Consumer Packaged Goods industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Promino Nutritional Sciences and its competitors. Promino Nutritional Sciences's current Cash Flow from Financing is $1.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promino Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Promino Nutritional Sciences (MUSLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.02 — trading 80% below its estimated fair value. The current Cash Flow from Financing is $1.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Promino Nutritional Sciences (MUSLF), the current Cash Flow from Financing is $1.08 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Promino Nutritional Sciences Business Description

Other Exchanges 93X:GermanyMUSL:Canada
Address 4145 North Service Road, 2nd Floor, Burlington, ON, CAN, L7L 6A3
Promino Nutritional Sciences Inc is a producer, distributor, and vendor of consumer-packaged nutritional products. Promino's product, Rejuvenate, is a patented proprietary formula that assists in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Promino also offers Promino, a performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury.